Correlation Between Unicycive Therapeutics and Viking Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Viking Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Viking Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Viking Therapeutics, you can compare the effects of market volatilities on Unicycive Therapeutics and Viking Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Viking Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Viking Therapeutics.
Diversification Opportunities for Unicycive Therapeutics and Viking Therapeutics
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Unicycive and Viking is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Viking Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viking Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Viking Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viking Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Viking Therapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Viking Therapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.64 times more return on investment than Viking Therapeutics. However, Unicycive Therapeutics is 1.64 times more volatile than Viking Therapeutics. It trades about 0.37 of its potential returns per unit of risk. Viking Therapeutics is currently generating about -0.36 per unit of risk. If you would invest 53.00 in Unicycive Therapeutics on September 12, 2024 and sell it today you would earn a total of 27.00 from holding Unicycive Therapeutics or generate 50.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Viking Therapeutics
Performance |
| Timeline |
| Unicycive Therapeutics |
| Viking Therapeutics |
Unicycive Therapeutics and Viking Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Viking Therapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Viking Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Viking Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viking Therapeutics will offset losses from the drop in Viking Therapeutics' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Viking Therapeutics vs. Terns Pharmaceuticals | Viking Therapeutics vs. Akero Therapeutics | Viking Therapeutics vs. Madrigal Pharmaceuticals | Viking Therapeutics vs. Sarepta Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |